Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8UDV

The X-RAY co-crystal structure of human FGFR3 V555M and Compound 17

Summary for 8UDV
Entry DOI10.2210/pdb8udv/pdb
Related8UDT 8UDU
DescriptorFibroblast growth factor receptor 3, SULFATE ION, 3-[(6-chloro-1-cyclopropyl-1H-benzimidazol-5-yl)ethynyl]-1-[(3S,5S)-5-(methoxymethyl)-1-(prop-2-enoyl)pyrrolidin-3-yl]-5-(methylamino)-1H-pyrazole-4-carboxamide, ... (5 entities in total)
Functional Keywordsfgfr inhibitor, covalent drug, kin-3248, alteration, mutation, structure-based drug design, kinase inhibitor, signaling, proliferation, transferase, transferase-inhibitor complex, transferase/inhibitor
Biological sourceHomo sapiens (human)
Total number of polymer chains3
Total formula weight103628.79
Authors
Primary citationTyhonas, J.S.,Arnold, L.D.,Cox, J.M.,Franovic, A.,Gardiner, E.,Grandinetti, K.,Kania, R.,Kanouni, T.,Lardy, M.,Li, C.,Martin, E.S.,Miller, N.,Mohan, A.,Murphy, E.A.,Perez, M.,Soroceanu, L.,Timple, N.,Uryu, S.,Womble, S.,Kaldor, S.W.
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations.
J.Med.Chem., 67:1734-1746, 2024
Cited by
PubMed: 38267212
DOI: 10.1021/acs.jmedchem.3c01819
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.348 Å)
Structure validation

222926

PDB entries from 2024-07-24

PDB statisticsPDBj update infoContact PDBjnumon